On January 13, 2020, a paper touting the creation of a possible therapy that could.
Heart disease patients with symptomatic COVID-19 are often treated with nirmatrelvir-ritonavir (Paxlovid) to prevent progression.
Recent studies have shown that patients with weakened immune systems—which enables the virus that causes.
Older people who were infected with COVID-19 show a substantially higher risk—as much as 50%.
An experimental drug used to fight cancer may reduce the risk of death for hospitalized.
Newly infected COVID-19 patients have two treatment options that can be taken at home. But.
Pfizer Inc. announced that it has launched a Phase 2/3 clinical trial of its COVID.